FOS and renal cell carcinoma: Furthermore, in addition to PI3K/Akt/mTOR signaling pathway, TAK1-dependent JNK/AP-1 and IKK pathways may also be important in the anticancer action of NVP-BEZ235 and PP242 against RCC (Figure 9).